MNPI Compliance in Private Equity (Screening Guide)

A sound MNPI screen asks what the information is, whether it is material and public, how it was obtained, and who has a duty to protect it. If any answer is uncertain, pause trading and disclosure, escalate to compliance or counsel, document the decision, and apply firm controls. A restricted list helps manage risk; it does not decide legality.

Could you make deal decisions with confidence while protecting your firm, investors, and career from an avoidable information breach? In private equity, sensitive information can arrive through diligence, lender discussions, portfolio-company work, advisers, or investor relations. The steps below offer a practical screen, not legal advice. Apply current law, firm policy, fund documents, and counsel’s direction to the facts.

MNPI Screening Overview, Legal Standards & Escalation

Material nonpublic information, or MNPI, is information that is both important to investors and not broadly available to them. A sound screen also asks how the information was obtained and whether a duty limits its use or disclosure. These questions guide escalation; they do not replace a legal review.

The main federal framework includes Securities Exchange Act Section 10(b) and Rule 10b-5. Rule 10b5-1 generally treats a person as trading “on the basis of” MNPI when aware of it at the time of the trade, subject to specified affirmative defenses. Do not assume a pre-existing trading plan protects a trade; counsel should confirm all applicable conditions.

Materiality has no universal price-movement test. In Basic Inc. v. Levinson, the Supreme Court described information as material when there is a substantial likelihood a reasonable investor would view it as significantly altering the total mix of available information. For a contingent event, such as a possible acquisition, assess both its probability and its magnitude.

Nonpublic status is a separate question. Ask whether the information was disseminated broadly enough to reach the investing public and whether the market had adequate time to absorb it. Sharing it with a lender, adviser, or selected investor does not automatically make it public.

A practical first-pass screen

Use these questions before receiving sensitive information, joining a deal process, trading, or sharing information:

• What is the information? Describe the specific fact, event, forecast, or decision. Avoid vague labels such as “deal data.”
• Could it matter to an investor? Consider the company, security, likely impact, probability, and size of the event. A small or uncertain event is not automatically immaterial.
• Is it public? Identify where and when it was released, who could access it, and whether enough time has passed for broad dissemination and absorption.
• How did it reach you? Record the source, date, relationship, confidentiality terms, and any limits on use.
• What securities or activity may be affected? Identify relevant issuers and securities, including possible trading, recommendations, or communications.
• Who needs to know? Limit access while compliance or counsel assesses the facts.

Rule 10b5-2 describes circumstances that may create a duty of trust or confidence, including an express agreement to keep information confidential, certain patterns of sharing and confidentiality, and certain family relationships. Whether a duty exists depends on the facts and applicable law. Do not treat information as freely usable simply because it came through a personal contact or an informal conversation.

Escalation decision table

These are screening prompts, not conclusions about legality. When uncertain, pause the relevant activity and escalate.

Deal-Team Information Controls, Restrictions & Documentation

Information controls reduce the chance that sensitive facts spread to people who do not need them. A restriction is a firm control, not the legal test for MNPI. A person may possess potentially material nonpublic information before compliance adds an issuer to a restricted list, so do not treat a missing listing as permission to trade.

Before a wall-crossing process, identify the issuer and securities, the information source, the confidentiality terms, and possible conflicts with trading or other work. A “wall crossing” is a controlled process for giving someone confidential information, often after the person agrees to limits. The process should be documented and handled under firm policy, not arranged informally.

Restrict access and document the decision

If information may be MNPI, compliance or counsel should decide what controls fit the facts and the firm’s policies. These may include adding securities to a restricted or watch list, limiting access to a deal team, applying information barriers, pausing relevant trading, or monitoring communications. A watch list may be confidential and used for surveillance; a restricted list may block or require approval for specified activity. Firms use these terms differently, so follow the firm’s definitions.

Document at least:

• The information’s source, date received, and relevant confidentiality terms.
• The issuer and securities under review, plus the reason for concern.
• The people who received or may access the information.
• The decision-maker, restriction applied, effective date, and review date.
• Any trading clearance, release, or other decision and its rationale.

Do not circulate the sensitive facts more widely just to explain a restriction. Share only what the reviewer needs, using approved channels. Keep records under firm policy and applicable legal requirements; do not set a retention period without checking those rules.

Illustrative screening scenarios

The following are training examples, not claims about specific firms or legal outcomes.

In my review of training scenarios, a recurring gap is treating “not on the restricted list” as a clearance. The safer lesson is simple: the list is one control, while the legal analysis depends on the information, its status, the person’s duty, and the circumstances.

Compliance Execution, Monitoring & Common Failure Points

A workable program links training, screening, restrictions, monitoring, and documented closure. The exact controls depend on the firm’s activities and legal duties. For SEC-registered investment advisers, Advisers Act Rule 206(4)-7 requires written compliance policies and procedures, an annual review, and a designated chief compliance officer.

Follow the process from preparation to closure

1. Prepare. Train investment, deal, operating, investor-relations, and support staff on materiality, public status, confidentiality, duties, escalation, and trading or tipping restrictions. Map where sensitive information enters and who can access it.
2. Screen and escalate. Before receiving details or joining a wall-crossed process, identify the issuer, security, source, terms, and potential conflicts. If the facts are unclear, ask compliance or counsel before proceeding.
3. Restrict and document. Apply controls under firm policy. Limit access to people with a business need, record the basis and decision-maker, and communicate the restriction without disclosing more than needed.
4. Monitor. Review relevant trading, communications, deal-team access, and restriction status under the firm’s procedures. Escalate changes, suspected leaks, accidental receipt, and attempted trading.
5. Close carefully. Remove a restriction only after documented compliance or legal review. Record the rationale and date, and retain records under applicable requirements and firm policy.

A pre-existing Rule 10b5-1 plan is not an automatic exception. The rule provides affirmative defenses only when specified conditions are met; requirements can vary by person and plan. Do not alter, adopt, or rely on a plan while aware of MNPI without counsel’s review.

Common failure points include assuming selected disclosure makes information public, relying on a price threshold to decide materiality, forwarding sensitive facts to a broad group, and treating an informal preclearance as a complete control. If you receive sensitive information by mistake, do not forward or act on it. Preserve relevant records and notify compliance promptly.

Career pathways tied to MNPI controls

Private-equity compliance work can sit in compliance, legal, risk, investment operations, or deal-team roles. Titles and duties vary by firm. Compliance professionals often manage policies, escalation, training, and surveillance; lawyers assess legal duties and advise on transactions; deal and operating staff identify risks early and follow access controls. These functions work best when each person knows when to stop and ask for review.

For a student or professional exploring this field, build knowledge of securities regulation, investment workflows, confidentiality, and written control processes. Practical experience with policy reviews, access logs, trade surveillance, or transaction diligence can help show how rules operate in context. Credentials and hiring expectations vary, so check role requirements and speak with practitioners before choosing a training path.

Conclusion and FAQ

A reliable MNPI process is not a one-time checklist. It is a documented sequence: identify the information and source, assess materiality and public status, consider duties, restrict access where appropriate, monitor, and close only after review. When uncertainty remains, pause relevant activity and escalate to compliance or counsel.

Is MNPI only information about public companies?
No. The analysis depends on the securities and circumstances involved. Information about a private or portfolio company may matter to investors in related publicly traded securities, including debt, depending on the facts.

Does sharing information with a lender make it public?
No. Limited disclosure to a lender or selected group does not automatically mean the information reached the investing public.

Is there a fixed price-movement threshold for materiality?
No. Materiality is a fact-specific legal assessment. A fixed percentage or price move is not a reliable substitute.

Can I trade if the issuer is not on the restricted list?
Not necessarily. A list is a firm control, not the legal test. If you may possess MNPI, pause and contact compliance or counsel.

What should I do if I receive confidential information by mistake?
Do not forward, trade, recommend a trade, or discuss it unnecessarily. Preserve relevant records and report the situation promptly under firm policy.

Does a confidentiality agreement automatically make information MNPI?
No. It can create duties or restrictions, but it does not by itself determine whether information is material or nonpublic. Assess all elements with compliance or counsel.

Can a pre-existing trading plan allow a trade while I know MNPI?
Possibly only if the plan meets the applicable affirmative-defense conditions. Do not rely on it without legal review of the plan and circumstances.

When may a restriction be removed?
Only after the firm’s authorized compliance or legal reviewer assesses the facts and documents the decision under firm policy. Do not remove it on your own.

What should an MNPI log record?
At minimum, record the source, timing, affected issuer or securities, people with access, restriction decision, decision-maker, and any review or release rationale.

Does this guide replace legal advice?
No. It is educational guidance. Apply current law, SEC guidance, firm policies, fund documents, and counsel’s direction to the specific facts.

(This article was written by one of our staff writers, James Holloway. Visit our Meet the Team page.)